FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroaki Nagano

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Treatment Outcome

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Daisaku Yamada; Hiroaki Nagano; Hiroshi Wada; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori
Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.
Sachiyo Yoshio; Takasuke Fukuhara; Norio Hayashi; Koyo Higashitani; Naoki Hiramatsu; Hisashi Ishida; Naruyasu Kakita; Tatsuya Kanto; Shoko Kuroda; Tokuhiro Matsubara; Yoshiharu Matsuura; Masashi Mizokami; Kazumoto Murata; Hiroaki Nagano; Masaya Sugiyama; Tetsuo Takehara
Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Masamitsu Konno; Toshihiro Kudoh; Masaki Mori; Hiroaki Nagano; Shimpei Nishikawa; Yuko Noguchi; Hisataka Ogawa; Katsuya Ohta; Miyuki Ozaki; Daisuke Sakai; Taroh Satoh; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi; Takahito Fukusumi; Atsushi Hamabe; Shinichiro Hasegawa; Yoshihiro Kano; Koichi Kawamoto; Hideshi Ishii
Adipose-derived mesenchymal stem cells and regenerative medicine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroaki Nagano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daisaku Yamada; Hiroaki Nagano; Hiroshi Wada; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori
Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.
European journal of cancer (Oxford, England : 1990) 2013;49(7):1725-40.
2013: Sachiyo Yoshio; Takasuke Fukuhara; Norio Hayashi; Koyo Higashitani; Naoki Hiramatsu; Hisashi Ishida; Naruyasu Kakita; Tatsuya Kanto; Shoko Kuroda; Tokuhiro Matsubara; Yoshiharu Matsuura; Masashi Mizokami; Kazumoto Murata; Hiroaki Nagano; Masaya Sugiyama; Tetsuo Takehara
Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Hepatology (Baltimore, Md.) 2013;57(5):1705-15.
2013: Masamitsu Konno; Toshihiro Kudoh; Masaki Mori; Hiroaki Nagano; Shimpei Nishikawa; Yuko Noguchi; Hisataka Ogawa; Katsuya Ohta; Miyuki Ozaki; Daisuke Sakai; Taroh Satoh; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi; Takahito Fukusumi; Atsushi Hamabe; Shinichiro Hasegawa; Yoshihiro Kano; Koichi Kawamoto; Hideshi Ishii
Adipose-derived mesenchymal stem cells and regenerative medicine.
Development, growth & differentiation 2013;55(3):309-18.
2013: Tokuhiro Matsubara; Masanori Miyazaki; Hiroaki Nagano; Mitsuru Sakakibara; Norio Hayashi; Koyo Higashitani; Naoki Hiramatsu; Naruyasu Kakita; Tatsuya Kanto; Akinori Kasahara; Shoko Kuroda; Yoshito Tomimaru; Akira Tomokuni; Sachiyo Yoshio; Tetsuo Takehara
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
Hepatology (Baltimore, Md.) 2013;57(4):1416-25.
2013: Masahiro Tanemura; Kiyomi Taniyama; Hidetoshi Eguchi; Wataru Kamiike; Eiji Miyoshi; Masaki Mori; Hiroaki Nagano; Yuichiro Doki
Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.
Cancer science 2013;104(3):282-90.
2013: Shogo Kobayashi; Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Koichi Kawamoto; Hiroaki Nagano; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Masaki Mori
Hepatectomy based on the tumor hemodynamics for hepatocellular carcinoma: a comparison among the hybrid and pure laparoscopic procedures and open surgery.
Surgical endoscopy 2013;27(2):610-7.
2013: Shogo Kobayashi; Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Koichi Kawamoto; Hiroaki Nagano; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Masaki Mori
Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved.
International journal of surgery (London, England) 2013;11(2):145-51.
2013: Tomohiko Machida; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano; Yoshiaki Ohmura; Yuichiro Doki; Hidetoshi Eguchi; Toshinori Ito; Shogo Kobayashi; Masahiro Tanemura; Tsukasa Tanida; Hiroshi Wada; Yoshiki Sawa
Significant Improvement in Islet Yield and Survival With Modified ET-Kyoto Solution: ET-Kyoto/Neutrophil Elastase Inhibitor.
Cell transplantation 2013;22(1):159-73.
2012: Atsushi Hosui; Tatsuya Kanto; Peter Klover; Masaki Mori; Hiroaki Nagano; Yuichiro Doki; Norio Hayashi; Lothar Hennighausen; Naoki Hiramatsu; Tomohide Tatsumi; Akio Uemura; Tetsuo Takehara
Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression.
International journal of cancer. Journal international du cancer 2012;131(12):2774-84.
2012: Tadafumi Asaoka; Yuichiro Doki; Hidetoshi Eguchi; Naoki Hama; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Phillip Ruiz; Hidenori Takahashi; Yutaka Takeda; Ichiro Takemasa; Masahiro Tanemura; Hiroshi Wada; Hiroaki Nagano
Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation.
The Journal of surgical research 2012;178(2):1003-14.
2012: Keita Okubo; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Hirofumi Akita; Yuichiro Doki; Hidetoshi Eguchi; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano
[A case report of total remnant pancreatectomy for ductal carcinoma after distal pancreatectomy for invasive intraductal papillary mucinous carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):2140-2.
2012: Kenta Furukawa; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hirofumi Akita; Yuichiro Doki; Hidetoshi Eguchi; Koji Umeshita; Hiroshi Wada; Hiroaki Nagano
[Surgical resection and S-1 administration for the treatment of hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1994-6.
2012: Sakae Maeda; Shigeru Marubashi; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi; Koichi Kawamoto; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Hiroaki Nagano
[A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1988-90.
2012: Shinichiro Hasegawa; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Hiroaki Nagano
[A case of advanced hepatocellular carcinoma with tumor thrombosis in the main trunk of the portal vein successfully treated by multidisciplinary therapies].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1867-9.
2012: Ryota Mukai; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Yuichirou Doki; Hidetoshi Eguchi; Kouichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano
[A case of advanced multiple hepatocellular carcinomas in both lobes that achieved long-term survival after repeated transcatheter arterial chemoembolization and surgical resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1837-9.
2012: Shinsuke Nakashima; Hiroshi Wada; Yuichiro Doki; Hidetoshi Eguchi; Koichi Kawamoto; Shogo Kobayashi; Masaki Mori; Hiroaki Nagano
[An elderly patient with hepatocellular carcinoma-treatment by transcatheter arterial chemoembolization and subsequent laparoscopic hepatectomy].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1828-30.
2012: Chihiro Yamanaka; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Hirofumi Akita; Yuichiro Doki; Hidetoshi Eguchi; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano
[A case of advanced hepatocellular carcinoma with inferior vena cava tumor thrombus and multiple intrahepatic metastases treated successfully by transcatheter arterial chemoembolization and radical hepatectomy].
Gan to kagaku ryoho. Cancer & chemotherapy 2012;39(12):1819-21.
2012: Hiroaki Nagano; Yuichiro Doki; Hidetoshi Eguchi; Naotsugu Haraguchi; Hideshi Ishii; Shigeru Marubashi; Masaki Mori
Novel therapeutic target for cancer stem cells in hepatocellular carcinoma.
Journal of hepato-biliary-pancreatic sciences 2012;19(6):600-5.
2012: Yoshito Tomimaru; Koji Umeshita; Hiroshi Wada; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano
Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function.
Digestive diseases and sciences 2012;57(7):1942-8.
2012: Ho Min Kim; Koshi Mimori; Yuichiro Doki; Hidetoshi Eguchi; Naotsugu Haraguchi; Hideshi Ishii; Hiroaki Nagano; Masahisa Ohkuma; Miho Okano; Mitsugu Sekimoto; Hirofumi Yamamoto; Masaki Mori
Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Annals of surgical oncology 2012;19 Suppl 3():S539-48.
2012: Daisaku Yamada; Hirofumi Yamamoto; Yuichiro Doki; Hidetoshi Eguchi; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Takehiro Noda; Masahiro Tanemura; Yoshito Tomimaru; Mamoru Uemura; Hiroshi Wada; Hiroaki Nagano
Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
Annals of surgical oncology 2012;19 Suppl 3():S355-64.
2012: Chiwan Kim; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Nobuaki Okumura; Toshifumi Takao; Yutaka Takeda; Masahiro Tanemura; Hiroshi Wada; Shintaro Aono; Yuichiro Doki; Hidetoshi Eguchi; Hiroaki Nagano
Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation.
The Journal of surgical research 2012;175(1):138-48.
2012: Hiromitsu Hoshino; Yuichiro Doki; Hidetoshi Eguchi; Takahito Fukusumi; Naotsugu Haraguchi; Yoshihiro Kano; Masaki Mori; Hiroaki Nagano; Shimpei Nishikawa; Miyuki Ozaki; Toshiyuki Saito; Daisuke Sakai; Taroh Satoh; Mitsugu Sekimoto; Akira Tomokuni; Hideshi Ishii
Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
International journal of oncology 2012;40(5):1423-30.
2012: Hiromitsu Onishi; Manabu Takamura; Mitsuaki Tatsumi; Noriyuki Tomiyama; Takahiro Tsuboyama; Kenichi Wakasa; Masatoshi Hori; Yasuharu Imai; Tonsok Kim; Seishi Kumano; Hiroaki Nagano; Atsushi Nakamoto; Yasuhiro Nakaya; Masahiro Okada; Takamichi Murakami
Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.
European radiology 2012;22(4):845-54.
2012: DyahLaksmi Dewi; Yuichiro Doki; Takahito Fukusumi; Naotsugu Haraguchi; Hideshi Ishii; Yoshihiro Kano; Susumu Miyazaki; Hiroaki Nagano; Shimpei Nishikawa; Katsuya Ohta; Miyuki Ozaki; Daisuke Sakai; Taroh Satoh; Masaki Mori
Reprogramming of gastrointestinal cancer cells.
Cancer science 2012;103(3):393-9.
2012: Masaru Kubota; Shigeru Marubashi; Morito Monden; Masaki Mori; Takamichi Murakami; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Masahiro Tanemura; Hiroshi Wada; Keizo Dono; Hidetoshi Eguchi; Shogo Kobayashi; Yuichiro Doki
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.
Digestive diseases and sciences 2012;57(3):801-5.
2011: Akira Tomokuni; Hiroshi Wada; Hidetoshi Eguchi; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano; Masahiro Tanemura; Yoshito Tomimaru; Yuichiro Doki
miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.
Biochemical and biophysical research communications 2011;414(4):675-80.
2011: Shogo Kobayashi; Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Hiroaki Nagano; Mitsugu Sekimoto; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Masaki Mori
Experience with the use of fibrin sealant plus polyglycolic acid felt at the cut surface of the liver in laparoscopic hepatectomy.
Surgical endoscopy 2011;25(11):3590-6.
2011: Shogo Kobayashi; Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Hiroaki Nagano; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Hiroshi Wada; Masaki Mori
Treatment of borderline cases for curative resection of biliary tract cancer.
Journal of surgical oncology 2011;104(5):499-503.
2011: Yoshito Tomimaru; Koji Umeshita; Hiroshi Wada; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori; Hiroaki Nagano
Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.
World journal of gastroenterology : WJG 2011;17(32):3709-15.
2011: H Akita; H Eguchi; O Ishikawa; Shogo Kobayashi; Shigeru Marubashi; Masatomo Mori; Hiroaki Nagano; H Ohigashi; H Takahashi; Yutaka Takeda; M Tanemura; Y Tomita; H Wada; Yuichiro Doki
Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
Oncogene 2011;30(31):3468-76.
2011: Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Shogo Kobayashi; Hiroaki Nagano; Yutaka Takeda; Masahiro Tanemura; Hiroshi Wada; Masaki Mori
Donor hepatectomy for living donor liver transplantation: learning steps and surgical outcome.
Digestive diseases and sciences 2011;56(8):2482-90.
2011: Norikatsu Miyoshi; Hideshi Ishii; Hiroaki Nagano; Naotsugu Haraguchi; Dyah Laksmi Dewi; Yoshihiro Kano; Shinpei Nishikawa; Masahiro Tanemura; Koshi Mimori; Fumiaki Tanaka; Toshiyuki Saito; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Reprogramming of mouse and human cells to pluripotency using mature microRNAs.
Cell stem cell 2011;8(6):633-8.
2011: Hiroaki Nagano; Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Hidetoshi Eguchi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
[Current status and problem about cadaveric liver transplantation in Japan].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2011;108(5):735-42.
2011: Yoshito Tomimaru; Hidetoshi Eguchi; Hiroshi Wada; Akira Tomokuni; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Masaki Mori; Yuichiro Doki; Hiroaki Nagano
Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells.
International journal of oncology 2011;38(5):1237-43.
2011: Shigeru Marubashi; Morito Monden; Keizo Dono; Shogo Kobayashi; Hiroaki Nagano; Yutaka Takeda; Koji Umeshita; Masaki Mori
Efficacy of minimal dosage of calcineurin inhibitor for living donor liver transplant recipients with preoperative renal dysfunction.
Hepato-gastroenterology 2011;58(106):508-11.
2011: Shogo Kobayashi; Shigeru Marubashi; Yuichiro Doki; Hidetoshi Eguchi; Hiroaki Nagano; Yutaka Takeda; Masahito Tanemura; Koji Umeshita; Hiroshi Wada; Masaki Mori
Successful adult ABO incompatible living donor liver transplantation: experience with double infusion through the hepatic artery and portal vein.
Hepato-gastroenterology 2011;58(106):503-7.
2011: Hiroaki Nagano; Katsuhiko Yanaga; Hiroshi Nishida; Koichi Kaneko; Ken Hoshino; Tadaaki Maehara; Munetaka Masuda; Hiroshi Matsufuji; Masato Nagino; Koichi Tabayashi; Ryuji Tominaga
[Induction of mid-level provider in the area of gastroenterological surgery--survey research in Osaka University Hospital].
Nihon Geka Gakkai zasshi 2011;112(2):139-42.
2011: Shogo Kobayashi; Hiroaki Nagano; Hiromitsu Hoshino; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Tonsok Kim; Eku Shimosegawa; Jun Hatazawa; Yuichiro Doki; Masaki Mori
Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
Journal of surgical oncology 2011;103(3):223-9.
2011: Takehiro Noda; Hiroaki Nagano; Yoshito Tomimaru; Masahiro Murakami; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Tonsok Kim; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery.
Surgery 2011;149(3):371-7.
2011: Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Yoshito Tomimaru; Takehiro Noda; Hiroshi Wada; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells.
Annals of surgical oncology 2011;18(2):589-96.
2011: Hiroaki Nagano; Keigo Osuga; Masahiro Tanemura; Yoshito Tomimaru; Koji Umeshita; Hiroshi Wada; Yuichiro Doki; Hidetoshi Eguchi; Shogo Kobayashi; Shigeru Marubashi; Masaki Mori
Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
Oncology 2011;80(1-2):63-9.
2011: Hidetoshi Eguchi; Hiroaki Nagano; Masahiro Tanemura; Yutaka Takeda; Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Koji Umeshita; Masaki Mori; Yuichiro Doki
A thick pancreas is a risk factor for pancreatic fistula after a distal pancreatectomy: selection of the closure technique according to the thickness.
Digestive surgery 2011;28(1):50-6.
2010: Yoshiaki Ohmura; Masahiro Tanemura; Naomasa Kawaguchi; Tomohiko Machida; Tsukasa Tanida; Takashi Deguchi; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Nariaki Matsuura; Toshinori Ito; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice.
Transplantation 2010;90(12):1366-73.
2010: Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Hiroshi Wada; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
A single-incision laparoscopic hepatectomy for hepatocellular carcinoma: initial experience in a Japanese patient.
Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 2010;19(6):367-71.
2010: Nobuyoshi Kittaka; Ichiro Takemasa; Shigeto Seno; Yutaka Takeda; Shogo Kobayashi; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Hiroaki Nagano; Hideo Matsuda; Morito Monden; Masaki Mori; Yuichiro Doki
Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
Annals of surgical oncology 2010;17(12):3145-54.
2010: Yoshito Tomimaru; Hiroshi Wada; Shigeru Marubashi; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Takehiro Noda; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma.
World journal of gastroenterology : WJG 2010;16(44):5603-10.
2010: Yoshito Tomimaru; Hidetoshi Eguchi; Hiroaki Nagano; Hiroshi Wada; A Tomokuni; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masatomo Mori
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.
British journal of cancer 2010;103(10):1617-26.
2010: Tsukasa Tanida; Masahiro Tanemura; Shogo Kobayashi; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Hiroshi Umeshita; Masaki Mori; Yuichirou Doki; Hiroaki Nagano
[A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(12):2729-31.
2010: Yoshiteru Katsura; Shogo Kobayashi; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Kenichi Wakasa; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
[A case of curative resected hilar bile duct cancer with hepatic artery and portal vein reconstructions].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(12):2720-2.
2010: Yasuji Hashimoto; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
[A long-term survival case of hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombi].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(12):2693-5.
2010: Daisaku Yamada; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2010;37(12):2670-2.
2010: Sachiyo Kogita; Yasuharu Imai; Masahiro Okada; Tonsok Kim; Hiromitsu Onishi; Manabu Takamura; Kazuto Fukuda; Takumi Igura; Yoshiyuki Sawai; Osakuni Morimoto; Masatoshi Hori; Hiroaki Nagano; Kenichi Wakasa; Norio Hayashi; Takamichi Murakami
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
European radiology 2010;20(10):2405-13.
2010: Yoshito Tomimaru; Hiroaki Nagano; Hidetoshi Eguchi; Shogo Kobayashi; Shigeru Marubashi; Hiroshi Wada; Masahiro Tanemura; Koji Umeshita; Naoki Hiramatsu; Tetsuo Takehara; Yuichiro Doki; Masaki Mori
Effects of preceding interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma.
Journal of surgical oncology 2010;102(4):308-14.
2010: Yoshito Tomimaru; Yutaka Takeda; Mitsuaki Tatsumi; Tonsok Kim; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Toru Kitagawa; Hiroaki Nagano; Koji Umeshita; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Oncology reports 2010;24(3):613-20.
2010: Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Hiroshi Wada; Koji Umeshita; Wakasa Kennichi; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Isolated metastasis to the gallbladder from hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2010;40(8):793-8.
2010: Hiroaki Nagano
Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon.
Oncology 2010;78 Suppl 1():142-7.
2010: Takashi Deguchi; Masahiro Tanemura; Eiji Miyoshi; Hiroaki Nagano; Tomohiko Machida; Yoshiaki Ohmura; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Toshinori Ito; Masaki Mori; Yuichiro Doki; Yoshiki Sawa
Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Cancer research 2010;70(13):5259-69.
2010: Takahiro Tsuboyama; Hiromitsu Onishi; Tonsok Kim; Hirofumi Akita; Masatoshi Hori; Mitsuaki Tatsumi; Atsushi Nakamoto; Hiroaki Nagano; Nariaki Matsuura; Kenichi Wakasa; Kaname Tomoda
Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
Radiology 2010;255(3):824-33.
2010: Shigeru Marubashi; Hiroaki Nagano; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori
Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
Journal of clinical pharmacology 2010;50(6):705-9.
2010: Yoshito Tomimaru; Hidetoshi Eguchi; Hiroshi Wada; Takehiro Noda; M Murakami; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masatomo Mori; Hiroaki Nagano
Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
British journal of cancer 2010;102(10):1483-90.
2010: Takeo Iwasaki; Isao Tachibana; Shigeyuki Yoshida; Kohki Shimazu; Yutaka Takeda; Hiroaki Nagano; Ichiro Kawase
A 61-year-old man with a lung nodule and elevated serum IgG.
Chest 2010;137(5):1232-5.
2010: Satoshi Shimizu; Tetsuo Takehara; Hayato Hikita; Takahiro Kodama; Takuya Miyagi; Atsushi Hosui; Tomohide Tatsumi; Hisashi Ishida; Takehiro Noda; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Norio Hayashi
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Journal of hepatology 2010;52(5):698-704.
2010: Ken-ichi Nagai; Hideshi Ishii; Norikatsu Miyoshi; Hiromitsu Hoshino; Toshiyuki Saito; Tetsuya Sato; Yoshito Tomimaru; Shogo Kobayashi; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Biochemical and biophysical research communications 2010;395(2):258-63.
2010: Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Hiroshi Wada; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Tonsok Kim; Yuichiro Doki; Masaki Mori
Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer.
Journal of surgical oncology 2010;101(5):376-83.
2010: Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Naoki Hama; Tadafumi Asaoka Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Yuichiro Doki; Masaki Mori
Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection.
Transplant international : official journal of the European Society for Organ Transplantation 2010;23(4):390-6.
2010: Masaki Okuyama; Hiroaki Nagano; Shogo Kobayashi; Li He; Hirofumi Ota; Junzo Shimizu; Yutaka Takeda; Shigeru Masrubashi; Hidetoshi Eguchi; Masahiro Tanemuea; Keizo Dono; Masato Sakon; Koji Umeshita; Mitsukazu Gotoh; Morito Monden
Role of the liver in determining alloimmune response in vitro following donor-specific spleen cell injection.
Transplant immunology 2010;22(3-4):150-6.
2010: Norikatsu Miyoshi; Hideshi Ishii; Ken-ichi Nagai; Hiromitsu Hoshino; Koshi Mimori; Fumiaki Tanaka; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Defined factors induce reprogramming of gastrointestinal cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(1):40-5.
2010: Shigeru Marubashi; Hiroaki Nagano; Eigoro Yamanouchi; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Noboru Maeda; Kaname Tomoda; Hayato Hikita; Shusaku Tsutsui; Yuichiro Doki; Masaki Mori
Salvage cystic duct anastomosis using a magnetic compression technique for incomplete bile duct reconstruction in living donor liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010;16(1):33-7.
2009: Hiromitsu Hoshino; Norikatsu Miyoshi; Ken-ichi Nagai; Yoshito Tomimaru; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer.
Biochemical and biophysical research communications 2009;390(3):1061-5.
2009: Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Yutaka Takeda; Masahiro Tanemura; Koji Konishi; Yasuo Yoshioka; Takehiro Inoue; Yuichiro Doki; Masaki Mori
Impact of postoperative irradiation after non-curative resection of hilar biliary cancer.
Journal of surgical oncology 2009;100(8):657-62.
2009: Tadafumi Asaoka; Tomoaki Kato; Shigeru Marubashi; Keizo Dono; Naoki Hama; Hidenori Takahashi; Shogo Kobayashi; Yutaka Takeda; Ichiro Takemasa; Hiroaki Nagano; Hideo Yoshida; Phillip Ruiz; Andreas G Tzakis; K Matsubara; Morito Monden; Yuichiro Doki; Masaki Mori
Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(12):1738-49.
2009: Shigeru Marubashi; Keizo Dono; Hiroaki Nagano; Shogo Kobayashi; Yutaka Takeda; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori
Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture.
Transplantation 2009;88(9):1123-30.
2009: Yoshiaki Ohmura; Yutaka Takeda; Hiroaki Nagano; Shoji Nakamori; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Toru Kitagawa; Morito Monden; Masaki Mori; Yuichiro Doki
[A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2428-9.
2009: Hiromitsu Hoshino; Yutaka Takeda; Hiroaki Nagano; Shoji Nakamori; Shogo Kobayashi; Hidetoshi Eguchi; Shigeru Marubashi; Masahiro Tanemura; Toru Kitagawa; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori
[A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2419-21.
2009: Daisuke Takiuchi; Masahiro Tanemura; Hiroaki Nagano; Yoshiaki Ohmura; Akira Tomokuni; Hironori Hatano; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Toru Kitagawa; Morito Monden; Masaki Mori; Yuichiro Doki
[A case of long-term survival for advanced gallbladder cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2395-7.
2009: Yoshito Tomimaru; Shogo Kobayashi; Hiroaki Nagano; Masahiro Murakami; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
[A long-term survival case of hepatocellular carcinoma with lymph node metastasis on the posterior surface of the pancreas head and portal vein tumor thrombus successfully treated with hepatopancreatoduodenectomy and adjuvant interferon-alpha and 5-fluorouracil combination therapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2389-91.
2009: Akira Tomokuni; Shigeru Marubashi; Hiroaki Nagano; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Toru Kitagawa; Keizo Dono; Morito Monden; Yuichiro Doki; Masaki Mori
[A case of complete response to S-1 therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2383-5.
2009: Hisanori Hatano; Shogo Kobayashi; Hiroaki Nagano; Akira Tomokuni; Yoshito Tomimaru; Masahiro Murakami; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(12):2374-6.
2009: Shigeru Marubashi; Keizo Dono; Hiroaki Nagano; Chiwan Kim; Tadafumi Asaoka; Naoki Hama; Shogo Kobayashi; Yutaka Takeda; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori
Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
Clinical transplantation 2009;23(6):904-13.
2009: Takehiro Noda; Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Keizo Dono; Koji Umeshita; Kenichi Wakasa; Morito Monden
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.
International journal of clinical oncology 2009;14(5):473-7.
2009: Yoshito Tomimaru; Hiroaki Nagano; Shigeru Marubashi; Shogo Kobayashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Toru Kitagawa; Koji Umeshita; Nobuyuki Hashimoto; Hideki Yoshikawa; Kenichi Wakasa; Yuichiro Doki; Masaki Mori
Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.
World journal of gastroenterology : WJG 2009;15(33):4204-8.
2009: Hiroaki Nagano; S Kishimoto; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Yoshito Tomimaru; Takehiro Noda; Koji Umeshita; Masato Sakon; Yuichiro Doki; Masaki Mori; Morito Monden
A safe protocol of intermittent hilar vascular clamping for hepatic resection in cirrhosis.
Hepato-gastroenterology 2009;56(94-95):1439-44.
2009: H Akita; Z Zheng; Yutaka Takeda; C Kim; N Kittaka; Shogo Kobayashi; Shigeru Marubashi; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Morito Monden; Masatomo Mori; Yuichiro Doki; Gerold Bepler
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.
Oncogene 2009;28(32):2903-9.
2009: Masafumi Shimoda; Shigeru Marubashi; Keizo Dono; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Hiroaki Nagano; Yoshihiko Hoshida; Morito Monden
ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high.
Hepato-gastroenterology 2009;56(93):1174-7.
2009: Ichiro Takemasa; Hideshi Ishii; Naotsugu Haraguchi; Koshi Mimori; Fumiaki Tanaka; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
[Perspectives on current status and future directions for cancer stem cells theory in gastrointestinal cancer].
Nihon Geka Gakkai zasshi 2009;110(4):207-12.
2009: Takehiro Noda; Hiroaki Nagano; Ichiro Takemasa; S Yoshioka; M Murakami; Hiroshi Wada; S Kobayashi; Shigeru Marubashi; Yutaka Takeda; Keizo Dono; Koji Umeshita; Nariaki Matsuura; K Matsubara; Yuichiro Doki; Masatomo Mori; Morito Monden
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
British journal of cancer 2009;100(10):1647-58.
2009: Naoki Hama; Yuka Yanagisawa; Keizo Dono; Shogo Kobayashi; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Shinya Watanabe; Yasuo Uchiyama; Morito Monden
Gene expression profiling of acute cellular rejection in rat liver transplantation using DNA microarrays.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(5):509-21.
2009: Shinichi Yoshioka; Ichiro Takemasa; Hiroaki Nagano; Nobuyoshi Kittaka; Takehiro Noda; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Koji Umeshita; Keizo Dono; Kenichi Matsubara; Morito Monden
Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 2009;45(5):881-9.
2009: Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Takehiro Noda; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.
BMC cancer 2009;9():361.
2008: Atsushi Miyamoto; Hiroaki Nagano; Yuichiro Doki; Yasuhiro Nagata; Takayuki Kanematsu; Morito Monden
[Questionnaire survey conducted by the Japan Surgical Society].
Nihon Geka Gakkai zasshi 2008;109(3):173-9.
2008: Masato Nakamura; Hiroaki Nagano; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Shogo Kobayashi; Hiroshi Wada; Takehiro Noda; Keizo Dono; Koji Umeshita; Morito Monden
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
Cancer 2008;112(8):1765-71.
2008: Nobuyoshi Kittaka; Ichiro Takemasa; Yutaka Takeda; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Keizo Dono; Kenichi Matsubara; Nariaki Matsuura; Morito Monden
Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
European journal of cancer (Oxford, England : 1990) 2008;44(6):885-97.
2008: Xundi Xu; Hirofumi Yamamoto; Guoxing Liu; Yasuhiro Ito; Chew Yee Ngan; Motoi Kondo; Hiroaki Nagano; Keizo Dono; Mitsugu Sekimoto; Morito Monden
CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
International journal of molecular medicine 2008;21(2):145-52.
2008: Shin Nakahira; Shoji Nakamori; Masaki Tsujie; Setsuo Takeda; Keishi Sugimoto; Yuji Takahashi; Jiro Okami; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.
Anticancer research 2008;28(1A):179-86.
2008: Hirofumi Akita; Hayato Hikita; Eigoro Yamanouchi; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Keizo Dono; Shusaku Tsutsui; Norio Hayashi; Morito Monden
Use of a metallic-wall stent in the magnet compression anastomosis technique for bile duct obstruction after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(1):118-20.
2007: Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yutaka Takeda; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
Cancer 2007;110(11):2493-501.
2007: Hirokazu Uyama; Hiroaki Nagano; Hideji Nakamura; Takamichi Murakami; Hironobu Nakamura; Morito Monden; Norio Hayashi
New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of beta-interferon and doxorubicin one-shot intra-arterial chemotherapy.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(12):1018-25.
2007: Masahiro Murakami; Hiroaki Nagano; Takehiro Noda; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Morito Monden
[A case of hepatocellular carcinoma with right atrium tumor thrombus treated with combined doxorubicin and interferon-beta/intra-arterial injection chemotherapy and hepatectomy].
Gan to kagaku ryoho. Cancer & chemotherapy 2007;34(12):2087-9.
2007: Takehiro Noda; Hiroaki Nagano; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Kenichi Wakasa; Morito Monden
[Surgical treatment for peritoneal seeding and needle-tract implantation of hepatocellular carcinoma after ultrasound-guided percutaneous puncture].
Gan to kagaku ryoho. Cancer & chemotherapy 2007;34(12):2080-3.
2007: Shigeru Marubashi; Keizo Dono; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Impact of graft size on postoperative thrombocytopenia in living donor liver transplant.
Archives of surgery (Chicago, Ill. : 1960) 2007;142(11):1054-8.
2007: Shigeru Marubashi; Keizo Dono; Hiroaki Nagano; Tadafumi Asaoka; Naoki Hama; Shogo Kobayashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Morito Monden
Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(11):1538-44.
2007: Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Isao Arai; Hideo Ota; Masato Nakamura; Bazarragchaa Damdinsuren; Takehiro Noda; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Yuichiro Doki; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Oncology reports 2007;18(4):801-9.
2007: Bazarragchaa Damdinsuren; Hiroaki Nagano; Morito Monden
Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37 Suppl 2():S238-50.
2007: Masafumi Shimoda; Shigeru Marubashi; Keizo Dono; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Utilization of autologous vein graft for replacement of the inferior vena cava in living-donor liver transplantation for obliterative hepatocavopathy.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(9):804-7.
2007: Masaki Tsujie; Shoji Nakamori; Shin Nakahira; Yuji Takahashi; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
Anticancer research 2007;27(4B):2241-9.
2007: Shigeru Marubashi; Keizo Dono; Hiroaki Nagano; Yukari Sugita; Tadafumi Asaoka; Naoki Hama; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Morito Monden
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(7):576-82.
2007: Hiroshi Wada; Hiroaki Nagano; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Masato Sakon; Kenichi Wakasa; Morito Monden
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Journal of gastroenterology 2007;42(6):501-6.
2007: Hiroaki Nagano; Masato Sakon; Morito Monden
[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2007;104(5):654-9.
2007: Tameyoshi Yamamoto; Hiroaki Nagano; Yasuharu Imai; Kazuto Fukuda; Hitoshi Matsumoto; Motoi Kondo; Hideo Ota; Masato Nakamura; Hiroshi Wada; Takehiro Noda; Bazarragchaa Damdinsuren; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Kenichi Wakasa; Morito Monden
Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
International journal of clinical oncology 2007;12(2):150-4.
2007: Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT.
Digestive diseases and sciences 2007;52(4):943-9.
2007: Shin Nakahira; Shoji Nakamori; Masaki Tsujie; Yuji Takahashi; Jiro Okami; Shinichi Yoshioka; Makoto Yamasaki; Shigeru Marubashi; Ichiro Takemasa; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.
International journal of cancer. Journal international du cancer 2007;120(6):1355-63.
2007: Yubo Yang; Hiroaki Nagano; Hideo Ota; Osakuni Morimoto; Masato Nakamura; Hiroshi Wada; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
Surgery 2007;141(2):196-202.
2007: Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshit; Shoji Nakamori; Morito Monden
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
Hepato-gastroenterology 2007;54(73):172-9.
2007: Isao Arai; Hiroaki Nagano; Motoi Kondo; Hirofumi Yamamoto; Nobuaki Hiraoka; Yurika Sugita; Hideo Ota; Shinichi Yoshioka; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Hitoshi Kato; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Hepato-gastroenterology 2007;54(73):167-71.
2007: Bazarragchaa Damdinsuren; Hiroaki Nagano; Hiroshi Wada; Takehiro Noda; Javzandulam Natsag; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Yuichiro Doki; Keizo Dono; Morito Monden
Interferon alpha receptors are important for antiproliferative effect of interferon-alpha against human hepatocellular carcinoma cells.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(1):77-83.
2007: Bazarragchaa Damdinsuren; Hiroaki Nagano; Hiroshi Wada; Motoi Kondo; Hideo Ota; Masato Nakamura; Takehiro Noda; Javzandulam Natsag; Hirofumi Yamamoto; Yuichiro Doki; Koji Umeshita; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
International journal of oncology 2007;30(1):201-8.
2007: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Bazarragchaa Damdinsuren; Takehiro Noda; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Keizo Dono; Morito Monden
Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Journal of hepatology 2007;46(1):77-88.
2006: Shigeru Marubashi; Keizo Dono; Yurika Sugita; Tadafumi Asaoka; Naoki Hama; Kunihito Gotoh; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Transplantation proceedings 2006;38(10):3640-2.
2006: Hiroshi Wada; Hiroaki Nagano; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Kenichi Wakasa; Morito Monden
[Surgical treatment for peritoneal dissemination of hepatocellular carcinoma after percutaneous ethanol injection therapy--a case report].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1935-7.
2006: Takehiro Noda; Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Yutaka Takeda; Koji Umeshita; Keizo Dono; Keigo Ohsuga; Tonsok Kim; Kaname Tomoda; Hironobu Nakamura; Morito Monden
[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1931-4.
2006: Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Takehiro Noda; Masato Nakamura; Hideo Ota; Bazarragchaa Damdinsuren; Shigeru Marubashi; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
[Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1848-51.
2006: Masato Nakamura; Hiroaki Nagano; Hiroshi Wada; Takehiro Noda; Hideo Ota; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
Journal of gastroenterology 2006;41(11):1120-5.
2006: Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging.
Oncology reports 2006;16(4):677-83.
2006: Takehiro Noda; Hiroaki Nagano; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Keigo Ohsuga; Tonsok Kim; Kaname Tomoda; Hironobu Nakamura; Morito Monden
[The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(9):1221-5.
2006: Masaki Tsujie; Shoji Nakamori; Shin Nakahira; Setsuo Takeda; Yuji Takahashi; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Pancreas 2006;33(2):142-7.
2006: Masaki Tsujie; Shoji Nakamori; Eiichi Tanaka; Hiroaki Nagano; Koji Umeshita; Keizo Dono; Masato Sakon; Takehiro Inoue; Toshihiko Inoue; Morito Monden
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Japanese journal of clinical oncology 2006;36(8):504-10.
2006: Hideo Ota; Hiroaki Nagano; Yuichiro Doki; Mitsugu Sekimoto; Motoi Kondo; Hiroshi Wada; Masato Nakamura; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
Oncology reports 2006;16(2):249-55.
2006: Masato Nakamura; Hiroaki Nagano; Takehiro Noda; Hiroshi Wada; Hideo Ota; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Yuichiro Doki; Koji Umeshita; Keizo Dono; Masato Sakon; Morito Monden
Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;35(4):289-95.
2006: Di Tang; Hiroaki Nagano; Masato Nakamura; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2006;10(7):987-98.
2006: Hiroaki Nagano; Morito Monden
[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(7):1314-8.
2006: Hidenori Takahashi; Shoji Nakamori; Shin Nakahira; Masaki Tsujie; Yuji Takahshi; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
Annals of surgical oncology 2006;13(7):955-60.
2006: Masato Nakamura; Hiroaki Nagano; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
[S-1 treatment against advanced HCC].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33 Suppl 1():230-5.
2006: Shigeru Marubashi; Keizo Dono; Tadafumi Asaoka; Naoki Hama; Kunihito Gotoh; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation.
Transplantation proceedings 2006;38(5):1407-10.
2006: Hiroshi Wada; Hiroaki Nagano; Hirofumi Yamamoto; Yubo Yang; Motoi Kondo; Hideo Ota; Masato Nakamura; Shinichi Yoshioka; Hitoshi Kato; Bazarragchaa Damdinsuren; Di Tang; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Masato Sakon; Keizo Dono; Kenichi Wakasa; Morito Monden
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(4):414-23.
2006: Di Tang; Hiroaki Nagano; Hirofumi Yamamoto; Hiroshi Wada; Masato Nakamura; Motoi Kondo; Hideo Ota; Shinichi Yoshioka; Hitoshi Kato; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Kenichi Wakasa; Morito Monden
Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
Oncology reports 2006;15(3):525-32.
2006: Kenya Yoshida; Yasuhiko Tomita; Yorihide Okuda; Shinji Yamamoto; Hirayuki Enomoto; Hirokazu Uyama; Hiroaki Ito; Yoshihiko Hoshida; Katsuyuki Aozasa; Hiroaki Nagano; Masato Sakon; Ichiro Kawase; Morito Monden; Hideji Nakamura
Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Annals of surgical oncology 2006;13(2):159-67.
2006: Bazarragchaa Damdinsuren; Hiroaki Nagano; Motoi Kondo; Javzandulam Natsag; Hiroyuki Hanada; Masato Nakamura; Hiroshi Wada; Hitoshi Kato; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
Oncology reports 2006;15(2):401-8.
2006: Shigeru Marubashi; Keizo Dono; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Liver transplantation for hepatitis C.
Journal of hepato-biliary-pancreatic surgery 2006;13(5):382-92.
2005: Shigeru Marubashi; Keizo Dono; Hiroaki Nagano; Kunihito Gotoh; Hidenori Takahashi; Kazuhiko Hashimoto; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Tomoaki Kato; Morito Monden
Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts.
Transplantation 2005;80(12):1671-5.
2005: Shouho Hayashi; Keizo Dono; Junzo Shimizu; Takamichi Murakami; Manabu Takamura; Tonsok Kim; Masatoshi Hori; Zhenhui Lu; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Hironobu Nakamura; Morito Monden
New measurement of hepatic blood flow by xenon CT system: an animal study with PGE1.
The Journal of surgical research 2005;129(1):24-30.
2005: Hitoshi Kato; Hiroaki Nagano; Hideo Ota; Masato Nakamura; Hiroshi Wada; Shinichi Yoshioka; Takahiro Noda; Damdinsuren Bazarragchaa; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Takamichi Murakami; Hironobu Nakamura; Morito Monden
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1842-5.
2005: Hiroshi Wada; Hiroaki Nagano; Masato Nakamura; Shinichi Yoshioka; Hitoshi Kato; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1835-8.
2005: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Shinichi Yoshioka; Hitoshi Kato; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Shoji Nakamori; Keizo Dono; Morito Monden
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(11):1824-8.
2005: Shigeru Marubashi; Keizo Dono; Koji Amano; Naoki Hama; Kunihito Gotoh; Hidenori Takahashi; Kazuhiko Hashimoto; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden
Steroid-free living-donor liver transplantation in adults.
Transplantation 2005;80(5):704-6.
2005: Hideo Ota; Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Motoi Kondo; Tameyoshi Yamamoto; Masato Nakamura; Bazarragchaa Damdinsuren; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
British journal of cancer 2005;93(5):557-64.
2005: Shigeru Marubashi; Keizo Dono; Masato Sakon; Kunihito Gotoh; Hidenori Takahashi; Kazuhiko Hashimoto; Masaru Kubota; Shinji Yamamoto; Atsushi Miyamoto; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Morito Monden
Portal venous reconstruction in a living liver donor with an anomalous hepatic arterial and portal venous anatomy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2005;9(3):365-8.
2005: Motoi Kondo; Hiroaki Nagano; Hiroshi Wada; Bazarragchaa Damdinsuren; Hirofumi Yamamoto; Nobuaki Hiraoka; Hidetoshi Eguchi; Atsushi Miyamoto; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1277-86.
2005: Bazarragchaa Damdinsuren; Hiroaki Nagano; Motoi Kondo; Hirofumi Yamamoto; Nobuaki Hiraoka; Tameyoshi Yamamoto; Shigeru Marubashi; Atsushi Miyamoto; Koji Umeshita; Keizo Dono; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
International journal of oncology 2005;26(2):319-27.
2005: Osakuni Morimoto; Hiroaki Nagano; Atsushi Miyamoto; Yoshiyuki Fujiwara; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Surgery today 2005;35(12):1033-41.
2004: Keigo Osuga; Takamichi Murakami; Saki Nakata; Kaname Tomoda; Hiroaki Nagano; Morito Monden; Hironobu Nakamura
[Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(13):2114-7.
2004: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Hiroshi Wada; Hidetoshi Eguchi; Motoi Kondo; Bazarragchaa Damdinsuren; Hideo Ota; Masato Nakamura; Hisashi Wada; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Hideo Yagita; Morito Monden
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7884-95.
2004: Shigeru Marubashi; Masato Sakon; Hiroaki Nagano; Kunihito Gotoh; Kazuhiko Hashimoto; Masaru Kubota; Shogo Kobayashi; Shinji Yamamoto; Atsushi Miyamoto; Keizo Dono; Shoji Nakamori; Koji Umeshita; Morito Monden
Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model.
Surgery 2004;136(5):1028-37.
2004: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Hiroshi Wada; Bazarragchaa Damdinsuren; Yubo Yang; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1939-42.
2004: Yutaka Kimura; Takushi Yasuda; Yoshiyuki Fujiwara; Shuji Takiguchi; Hiroshi Miyata; Hiroaki Nagano; Masahiko Yano; Morito Monden
[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1825-7.
2004: Hiroshi Wada; Hiroaki Nagano; Keizo Dono; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shinichi Yoshioka; Bazarragchaa Damdinsuren; Yang Yubo; Shigeru Marubashi; Atsushi Miyamoto; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1711-3.
2004: Shigeru Marubashi; Keizo Dono; Hidenori Takahashi; Kazuhiko Hashimoto; Masaru Kubota; Shinji Yamamoto; Atsushi Miyamoto; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(11):1708-10.
2004: Chang De Jin; Tameyoshi Yamamoto; Masato Nakamura; Isao Arai; Rho Kishin; Xu Xing; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(10):1511-5.
2004: Yukinori Kurokawa; Ryo Matoba; Hiroaki Nagano; Masato Sakon; Ichiro Takemasa; Shoji Nakamori; Keizo Dono; Koji Umeshita; Noriko Ueno; Shin Ishii; Kikuya Kato; Morito Monden
Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6029-38.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Norishige Iizuka; Shigeru Marubashi; Atsushi Miyamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Katsuyuki Aozasa; Morito Monden
Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
Journal of gastroenterology 2004;39(8):793-7.
2004: Yukinori Kurokawa; Ryo Matoba; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Masato Sakon; Noriko Ueno; Shigeyuki Oba; Shin Ishii; Kikuya Kato; Morito Monden
Molecular-based prediction of early recurrence in hepatocellular carcinoma.
Journal of hepatology 2004;41(2):284-91.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Takaya Morooka; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Shoji Nakamori; Morito Monden; Katsuyuki Aozasa
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2846-50.
2004: Takamichi Murakami; Masatoshi Hori; Tonsok Kim; Kazuhiko Hashimoto; Keizo Dono; Shoho Hayashi; Eiji Sugihara; Hiroaki Nagano; Shigeru Sase; Masato Sakon; Morito Monden; Hironobu Nakamura
Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma.
Investigative radiology 2004;39(4):210-5.
2004: Yukinori Kurokawa; Ryo Matoba; Shoji Nakamori; Ichiro Takemasa; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden; Kikuya Kato
PCR-array gene expression profiling of hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR 2004;23(1):135-41.
2004: Shogo Kobayashi; Masatoshi Hori; Keizo Dono; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Masato Sakon; Keigo Osuga; Keiji Umetani; Takamichi Murakami; Hironobu Nakamura; Morito Monden
In vivo real-time microangiography of the liver in mice using synchrotron radiation.
Journal of hepatology 2004;40(3):405-8.
2004: Minoru Ogawa; Hirofumi Yamamoto; Hiroaki Nagano; Yasuhiro Miyake; Yurika Sugita; Taishi Hata; Byung-No Kim; Chew Yee Ngan; Bazarragchaa Damdinsuren; Masakazu Ikenaga; Masataka Ikeda; Masayuki Ohue; Shoji Nakamori; Mitsugu Sekimoto; Masato Sakon; Nariaki Matsuura; Morito Monden
Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
Hepatology (Baltimore, Md.) 2004;39(2):528-39.
2004: Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Shoji Nakamori; Morito Monden; Katsuyuki Aozasa
Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Annals of surgical oncology 2004;11(2):165-72.
2004: Taro Aoki; Atsushi Miyamoto; Shigeru Marubashi; Hiroaki Nagano; Koji Umeshita; Yoshiyuki Fujiwara; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
International journal of oncology 2004;24(2):441-6.
2004: Shinji Yamamoto; Yasuhiko Tomita; Shoji Nakamori; Yoshihiko Hoshida; Norishige Iizuka; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Osamu Ishikawa; Hiroaki Ohigashi; Katsuyuki Aozasa; Morito Monden
Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
Oncology 2004;66(6):468-75.
2004: Shoji Nakamori; Masanori Tujie; Yuji Takahashi; Shigeru Maruhashi; Atsushi Miyamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(1):51-4.
2004: Xundi Xu; Masato Sakon; Hiroaki Nagano; Nobuaki Hiraoka; Hirofumi Yamamoto; Nobuyasu Hayashi; Keizo Dono; Shoji Nakamori; Koji Umeshita; Yasuhiro Ito; Nariaki Matsuura; Morito Monden
Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
Oncology reports 2004;11(1):25-32.
2004: Nobuyasu Hayashi; Shoji Nakamori; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Hisashi Narimatsu; Morito Monden
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):26-34.
2004: Shinji Yamamoto; Shoji Nakamori; Masaki Tsujie; Yuji Takahashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Yasuhiko Tomita; Yoshihiko Hoshida; Katsuyuki Aozasa; Kimitoshi Kohno; Morito Monden
Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(1):12-8.
2003: Bazarragchaa Damdinsuren; Hiroaki Nagano; Masato Sakon; Motoi Kondo; Tameyoshi Yamamoto; Koji Umeshita; Keizo Dono; Shoji Nakamori; Morito Monden
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Annals of surgical oncology 2003;10(10):1184-90.
2003: Yukinori Kurokawa; Ryo Matoba; Ichiro Takemasa; Shoji Nakamori; Masaki Tsujie; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Noriko Ueno; Hiroko Kita; Shigeyuki Oba; Shin Ishii; Kikuya Kato; Morito Monden
Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study.
Journal of hepatology 2003;39(6):1004-12.
2003: Hiroaki Nagano; Masato Sakon; Morito Monden
[The chemotherapy for hepatocellular carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(12):1895-900.
2003: Jiro Okami; Keizo Dono; Masato Sakon; Masaki Tsujie; Nobuyasu Hayashi; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Shoji Nakamori; Morito Monden
Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(7):850-6.
2003: Masato Nakamura; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Hideo Ota; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Naoki Hiramatsu; Norio Hayashi; Morito Monden
[A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1717-21.
2003: Hideo Ota; Hiroaki Nagano; Masato Sakon; Tameyoshi Yamamoto; Masato Nakamura; Shigeru Marubashi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Takamichi Murakami; Hironobu Nakamura; Morito Monden
[A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1673-7.
2003: Masaki Tsujie; Shoji Nakamori; Jiro Okami; Nobuyasu Hayashi; Nobuaki Hiraoka; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Experimental cell research 2003;289(1):143-51.
2003: Junzo Shimizu; Hiroshi Oka; Keizo Dono; Masato Sakon; Manabu Takamura; Takamichi Murakami; Shouho Hayashi; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Shigeru Sase; Mitsukazu Gotoh; Kenichi Wakasa; Hironobu Nakamura; Morito Monden
Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.
Digestive diseases and sciences 2003;48(8):1510-6.
2003: Hirofumi Yamamoto; Motoi Kondo; Shoji Nakamori; Hiroaki Nagano; Kenichi Wakasa; Yurika Sugita; Jin Chang-De; Shogo Kobayashi; Bazarragchaa Damdinsuren; Keizo Dono; Koji Umeshita; Mitsugu Sekimoto; Masato Sakon; Nariaki Matsuura; Morito Monden
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Gastroenterology 2003;125(2):556-71.
2003: Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Terumasa Yamada; Hidewaki Nakagawa; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Yo Sasaki; Osamu Ishikawa; Shingi Imaoka; Morito Monden
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.
Journal of hepatology 2003;39(2):215-21.
2003: Masaki Tsujie; Shoji Nakamori; Jiro Okami; Yuji Takahashi; Nobuyasu Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
International journal of oncology 2003;23(2):325-31.
2003: Shogo Kobayashi; Keizo Dono; Shiro Takahara; Yoshitaka Isaka; Enyu Imai; Lu Zhenhui; Hiroaki Nagano; Kato Tomoaki; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation.
The journal of gene medicine 2003;5(6):510-7.
2003: Atsushi Miyamoto; Tomoaki Kato; Keizo Dono; Koji Umeshita; Ryohei Kawabata; Shoho Hayashi; Masaru Kubota; Shogo Kobayashi; Hiroaki Nagano; Shoji Nakamori; Masato Sakon; Morito Monden
Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral.
Transplantation 2003;75(9):1596-8.
2003: Xundi Xu; Hirofumi Yamamoto; Masato Sakon; Masayoshi Yasui; Chew Yee Ngan; Hiroki Fukunaga; Tetsushi Morita; Minoru Ogawa; Hiroaki Nagano; Shoji Nakamori; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1764-72.
2003: Motoi Kondo; Hiroaki Nagano; Masato Sakon; Shouho Hayashi; Jiro Okami; Keizo Dono; Koji Umeshita; Shoji Nakamori; Ken-ichi Wakasa; Morito Monden
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma.
Hepato-gastroenterology 2003;50(50):504-6.
2003: Shogo Kobayashi; Keizo Dono; Toshiyuki Tanaka; Shiro Takahara; Yoshitaka Isaka; Enyu Imai; Hiroaki Nagano; Kato Tomoaki; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation.
The journal of gene medicine 2003;5(3):201-8.
2003: Masaki Tsujie; Shoji Nakamori; Shoichi Nakazuru; Nobuyasu Hayashi; Jiro Okami; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(2):297-301.
2003: Shinji Yamamoto; Yasuhiko Tomita; Shoji Nakamori; Yoshihiko Hoshida; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden; Katsuyuki Aozasa
Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):447-52.
2003: Jiro Okami; Shoji Nakamori; Nobuaki Hiraoka; Masaki Tsujie; Nobuyasu Hayashi; Hirofumi Yamamoto; Yoshiyuki Fujiwara; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.
Clinical & experimental metastasis 2003;20(7):577-84.
2002: Jiro Okami; Shoji Nakamori; Hitoshi Yamamoto; Masato Sakon; Masaki Tsujie; N Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; O Ishikawa; H Ohigashi; Morito Monden
An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Journal of experimental & clinical cancer research : CR 2002;21(4):569-76.
2002: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Takushi Yasuda; Hiroyoshi Takemoto; Tadashi Tsujino; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masahiko Yano; Keigo Osuga; Takamichi Murakami; Hironobu Nakamura; Morito Monden
[A case of postoperative multiple hepatic metastasis from gastric cancer successfully treated by percutaneous microwave coagulation therapy and hepatic arterial infusion chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2429-32.
2002: Hideo Ota; Hiroaki Nagano; Masato Sakon; Tsuyoshi Inoue; Shoho Hayashi; Motoi Kondo; Isao Arai; Osakuni Morimoto; Tameyoshi Yamamoto; Masato Nakamura; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
[Hepatocellular carcinoma recurrence in PEI site--a case report].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(12):2421-4.
2002: Hiroaki Nagano; Masato Sakon; Morito Monden
[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
Nihon rinsho. Japanese journal of clinical medicine 2002;60(11):2237-44.
2002: Keigo Osuga; Azzam Anwar Khankan; Shinichi Hori; Atsuya Okada; Takashi Sugiura; Munehiro Maeda; Hiroaki Nagano; Akira Yamada; Takamichi Murakami; Hironobu Nakamura
Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience.
Journal of vascular and interventional radiology : JVIR 2002;13(9 Pt 1):929-34.
2002: Motoi Kondo; Keizo Dono; Masato Sakon; Junzo Shimizu; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Ken-ichi Wakasa; Morito Monden
Adenosquamous carcinoma of the gallbladder.
Hepato-gastroenterology 2002;49(47):1230-4.
2002: Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Yamada; Sumio Kawata; Yasuharu Imai; Shohei Iijima; Morito Monden
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.
Cancer 2002;94(2):435-42.
2002: Hidetoshi Eguchi; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Morito Monden
A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.
Surgery today 2002;32(8):742-6.
2002: Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Keizo Dono; Koji Umeshita; Manabu Takamura; Takamichi Murakami; Shoji Nakamori; Hironobu Nakamura; Morito Monden
Liver abscess formation after microwave coagulation therapy applied for hepatic metastases from surgically excised bile duct cancer: report of a case.
Surgery today 2002;32(5):454-7.
2002: Masato Sakon; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Koji Umeshita; Takamichi Murakami; Hironobu Nakamura; Morito Monden
Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(1):94-9.
2001: Hiroaki Nagano; Hidetoshi Eguchi; Masato Sakon; Morito Monden
[Hepatic arterial infusion chemotherapy combined with interferon-alpha for hepatocellular carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 6():748-52.
2001: Tameyoshi Yamamoto; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Takamichi Murakami; Hideji Nakamura; Morito Monden
[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1718-23.
2001: Hiroaki Nagano; Masato Sakon; Takushi Yasuda; Keizo Dono; Shoji Nakamori; Masahiko Yano; Koji Umeshita; Hitoshi Shiozaki; Akira Okada; Takamichi Murakami; Hideji Nakamura; Morito Monden
[A case of postoperative multiple hepatic metastasis from esophageal cancer successfully treated by surgical resection and hepatic arterial infusion chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1628-31.
2001: Shingo Noura; Mitsugu Sekimoto; Hitoshi Yamamoto; Masataka Ikeda; Masakazu Ikenaga; Yasuhiro Miyake; S Yokoyama; Hiroaki Nagano; Masato Sakon; Morito Monden
[Significance of liver resection for multiple hepatic metastases from colorectal cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(11):1550-3.
2001: Norio Hayashi; Hitoshi Yamamoto; Nobuaki Hiraoka; Keizo Dono; Yasuhiro Ito; Jiro Okami; Motoi Kondo; Hiroaki Nagano; Koji Umeshita; Masato Sakon; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hepatology (Baltimore, Md.) 2001;34(4 Pt 1):638-50.
2001: K Shiozaki; Shoji Nakamori; Masaki Tsujie; Jiro Okami; Hitoshi Yamamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; H Furukawa; M Hiratsuka; T Kasugai; S Ishiguro; Morito Monden
Human stomach-specific gene, CA11, is down-regulated in gastric cancer.
International journal of oncology 2001;19(4):701-7.
2001: Atsushi Miyamoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Yurika Sugita; Hidetoshi Eguchi; Motoi Kondo; Isao Arai; Osakuni Morimoto; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR.
International journal of oncology 2001;18(3):527-32.
2001: M Wang; Masato Sakon; Koji Umeshita; M Okuyama; K Shiozaki; Hiroaki Nagano; K Dohno; Shoji Nakamori; Morito Monden
Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain mu activation.
Journal of hepatology 2001;34(2):278-83.
2001: Masato Sakon; Yasuhisa Aono; Hideo Ariyoshi; Atsushi Ueda; Yoshihisa Tsuji; Koji Umeshita; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Morito Monden
Involvement of calcium influx in hypoxia-induced bleb formation in human umbilical vein endothelial cells.
Transplantation proceedings 2001;33(1-2):898.
2000: Atsushi Miyamoto; Koji Umeshita; Masato Sakon; Hiroaki Nagano; Hiroshi Eguchi; S Kishimoto; Keizo Dono; Shoji Nakamori; M Gotoh; Morito Monden
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Journal of gastroenterology and hepatology 2000;15(12):1447-51.
2000: Masato Sakon; Koji Umeshita; Hiroaki Nagano; H Eguchi; S Kishimoto; Atsushi Miyamoto; S Ohshima; Keizo Dono; Shoji Nakamori; M Gotoh; Morito Monden
Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves.
Archives of surgery (Chicago, Ill. : 1960) 2000;135(12):1456-9.
2000: L He; Keizo Dono; M Gotoh; M Okumura; Yutaka Takeda; J Shimizu; Hiroaki Nagano; S Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
Role of the liver in alloimmune response following inoculation of donor spleen cells.
Cell transplantation 2000;9(5):725-8.
2000: Hidetoshi Eguchi; Koji Umeshita; Masato Sakon; Hiroaki Nagano; Yasuhiro Ito; S I Kishimoto; Keizo Dono; Shoji Nakamori; Tsutomu Takeda; Mitsukazu Gotoh; Kenichi Wakasa; Nariaki Matsuura; Morito Monden
Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.
Digestive diseases and sciences 2000;45(7):1383-8.
2000: Atsushi Miyamoto; Y Fujiwara; Masato Sakon; Hiroaki Nagano; Y Sugita; M Kondo; Hidetoshi Eguchi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Morito Monden
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Digestive diseases and sciences 2000;45(7):1376-82.
2000: Hidetoshi Eguchi; Hiroaki Nagano; Hitoshi Yamamoto; Atsushi Miyamoto; Motoi Kondo; Keizo Dono; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2881-90.
2000: Motoi Kondo; Hiroaki Nagano; Masato Sakon; Hitoshi Yamamoto; Osakuni Morimoto; Isao Arai; Atsushi Miyamoto; Hidetoshi Eguchi; Keizo Dono; Shoji Nakamori; Koji Umeshita; Kenichi Wakasa; Y Ohmoto; Morito Monden
Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
International journal of oncology 2000;17(1):83-8.
2000: S Kishimoto; Masato Sakon; Koji Umeshita; Hideyuki Miyoshi; Kazunori Taniguchi; W Meng; Hiroaki Nagano; Keizo Dono; H Ariyosi; Shoji Nakamori; Tomio Kawasaki; M Gotoh; Morito Monden; S Imajoh-Ohmi
The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation.
Transplantation 2000;69(11):2314-9.
2000: Jiro Okami; K Dohno; Masato Sakon; Kyoko Iwao; Terumasa Yamada; Hitoshi Yamamoto; Yoshiyuki Fujiwara; Hiroaki Nagano; Koji Umeshita; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2326-32.
2000: Terumasa Yamada; Shoji Nakamori; Hiroki Ohzato; Naozumi Higaki; Taro Aoki; S Oshima; K Shiozaki; Jiro Okami; Nobuyasu Hayashi; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Masato Sakon; Morito Monden
Outcome of pancreatic cancer patients based on genetic lymph node staging.
International journal of oncology 2000;16(6):1165-71.
2000: Yoshiyuki Fujiwara; Yurika Sugita; Shoji Nakamori; Atsushi Miyamoto; K Shiozaki; Hiroaki Nagano; Masato Sakon; Morito Monden
Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.
International journal of oncology 2000;16(4):799-804.
2000: Y Ito; Morito Monden; T Takeda; Hidetoshi Eguchi; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Masato Sakon; Masato Nakamura; M Tsujimoto; M Nakahara; K Nakao; Y Yokosaki; Nariaki Matsuura
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
British journal of cancer 2000;82(6):1211-7.
1999: K Gotoh; Hiroaki Nagano; Masato Sakon; Atsushi Miyamoto; J Shimizu; H Taniguchi; Keizo Dono; Shoji Nakamori; Koji Umeshita; M Gotoh; Hideji Nakamura; Kenichi Wakasa; Morito Monden
[A case of mucinous cholangiocarcinoma with lymph node metastasis].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 1999;96(12):1401-6.
1999: Motoi Kondo; Hitoshi Yamamoto; Hiroaki Nagano; Jiro Okami; Y Ito; J Shimizu; Hidetoshi Eguchi; Atsushi Miyamoto; Keizo Dono; Koji Umeshita; Nariaki Matsuura; Ken-ichi Wakasa; Shoji Nakamori; Masato Sakon; Morito Monden
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4005-12.
1999: L He; M Gotoh; Keizo Dono; Hiroaki Nagano; H Ota; Y Ohta; M Okuyama; Yutaka Takeda; J Shimizu; TR Grochowiecki; Masato Sakon; Morito Monden
Participation of the liver in generation of a vigorous anti-donor response after inoculation of donor spleen cells.
Transplantation 1999;68(7):950-7.
1999: Y Ito; Nariaki Matsuura; Masato Sakon; T Takeda; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; M Tsujimoto; M Nakahara; K Nakao; Morito Monden
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
British journal of cancer 1999;81(4):747-51.
1999: Junzo Shimizu; Hiroaki Nagano; Masato Sakon; Keizo Dono; Yutaka Takeda; S Kishimoto; Hidetoshi Eguchi; Atsushi Miyamoto; Motoi Kondo; Shoji Nakamori; Koji Umeshita; Hideji Nakamura; Kenichi Wakasa; Morito Monden
[A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(12):1895-9.
1999: Shoji Nakamori; S Nishihara; Y Ikehara; Hiroaki Nagano; Keizo Dono; Masato Sakon; Hisashi Narimatsu; Morito Monden
Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas.
Journal of experimental & clinical cancer research : CR 1999;18(3):425-32.
1999: Jiro Okami; Hitoshi Yamamoto; Yoshiyuki Fujiwara; Masaki Tsujie; Motoi Kondo; Shingo Noura; S Oshima; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Osamu Ishikawa; Masato Sakon; Nariaki Matsuura; Shoji Nakamori; Morito Monden
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2018-24.
1999: Junzo Shimizu; Keizo Dono; Mitsukazu Gotoh; Y Hasuike; Tonsok Kim; Takamichi Murakami; Masato Sakon; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; N Kato; T Miyazawa; Hironobu Nakamura; Morito Monden
Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging.
Digestive diseases and sciences 1999;44(7):1330-7.
1999: Yasuhiro Ito; Nariaki Matsuura; Masato Sakon; Eiji Miyoshi; Katsuhisa Noda; Tsutomu Takeda; Koji Umeshita; Hiroaki Nagano; Shoji Nakamori; Keizo Dono; Masahiko Tsujimoto; M Nakahara; Kazuwa Nakao; Naoyuki Taniguchi; Morito Monden
Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Hepatology (Baltimore, Md.) 1999;30(1):90-9.
1999: T Grtochowiecki; M Gotoh; Keizo Dono; Yutaka Takeda; M Nishihara; Y Ohta; H Ota; Hiroki Ohzato; M Okuyama; J Shimizu; F Kimura; L He; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Masato Sakon; Morito Monden
Pretreatment of crude pancreatic islets with mitomycin C prolongs graft survival time in xenogeneic rat-to-mouse model.
Transplantation 1999;67(11):1474-7.
1999: T Tanigawa; M Gotoh; Hiroaki Nagano; H Ota; T Fukuzaki; Masato Sakon; Morito Monden
Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats.
Transplantation 1999;67(5):653-8.
1999: TR Grochowiecki; M Gotoh; Keizo Dono; Yutaka Takeda; Hiroki Ohzato; M Okuyama; J Shimizu; F Kimura; L He; Hiroaki Nagano; S Nakamori; Koji Umeshita; Masato Sakon; Hideo Yagita; K Okumura; Morito Monden
Pretreatment of islets with mitomycin C and blockage of costimulatory signal induces unresponsiveness to islet xenografts.
Transplantation proceedings 1999;31(1-2):925.
1999: Yutaka Takeda; M Gotoh; Keizo Dono; TR Grochowiecki; F Kimura; M Okuyama; J Shimizu; Hiroaki Nagano; Koji Umeshita; Masato Sakon; Masayuki Miyasaka; Morito Monden
Acceptance of islet allografts transplanted with Fas ligand expressing testicular allografts.
Transplantation proceedings 1999;31(1-2):624.
1999: Koji Umeshita; M Gotoh; J Shimizu; Yutaka Takeda; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Masato Sakon; J Okamura; Morito Monden
Evaluation of patient selection criteria for liver transplantation: eight-year experience.
Transplantation proceedings 1999;31(1-2):376-7.
1999: H Ota; M Gotoh; Hiroki Ohzato; L He; T Tanigawa; Hiroaki Nagano; Keizo Dono; Yutaka Takeda; M Okuyama; J Shimizu; Koji Umeshita; Shoji Nakamori; Masato Sakon; Isamu Nishisho; Morito Monden
Microchimerism in thymus is associated with up-regulated T helper type 1 cytokine transcription during cardiac allograft rejection in rats.
Transplantation 1999;67(1):165-73.
1996: T Tanigawa; M Gotoh; H Ota; Hiroaki Nagano; Hiroki Ohzato; Yasunori Hasuike; Masato Sakon; Morito Monden
Prolongation of cardiac allograft survival by intraportal injection of donor antigens--differential mechanisms according to the timing of injection.
Cell transplantation 1996;5(5 Suppl 1):S79-80.
1995: Hiroaki Nagano; T Tanigawa; Toshiomi Yoshida; H Ota; K Akagi; Yasunori Hasuike; M Gotoh; Isamu Nishisho; Morito Monden
Role of micro-chimerism in inducing immunological tolerance by intraportal injection of donor spleen cells in rats.
Cell transplantation 1995;4 Suppl 1():S59-60.
1994: Hiroaki Nagano; Morito Monden; M Gotoh; T Tanigawa; Yasunori Hasuike; K Akagi; Toshiomi Yoshida; H Ota; Isamu Nishisho; T Mori
Existence of microchimerism in the spleen after intraportal injection in molecular-biological and immunofluorescence study.
Transplantation proceedings 1994;26(6):3471.
1994: T Tanigawa; Morito Monden; M Gotoh; Hiroaki Nagano; Yasunori Hasuike; T Fukuzaki; K Akagi; Toshiomi Yoshida; H Ota; T Mori
Pretreatment of recipients with mitomycin-C-treated spleen cells induces significant prolongation of cardiac allograft survival in rats.
Transplantation proceedings 1994;26(6):3359-60.
1994: T Tanigawa; Morito Monden; Hiroaki Nagano; Yasunori Hasuike; M Gotoh; T Fukuzaki; H Ota; Toshiomi Yoshida; T Mori
Portal tolerance in rats: effect of donor cell treatment and timing of administration.
Transplantation proceedings 1994;26(4):1870-1.
1994: Hiroaki Nagano; Morito Monden; M Gotoh; T Tanigawa; Yasunori Hasuike; K Akagi; Toshiomi Yoshida; H Ota; Isamu Nishisho; T Mori
Restriction fragment length polymorphism analysis to detect microchimerism at the DNA level in rats.
Transplantation proceedings 1994;26(4):1970-1.
1994: T Fukuzaki; M Gotoh; Yasunori Hasuike; T Tanigawa; Hiroaki Nagano; Koji Umeshita; T Kanai; Morito Monden; T Mori
Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.
Transplantation proceedings 1994;26(2):779.
1993: Hiroaki Nagano; Morito Monden; M Gotoh; T Tanigawa; T Tono; Y Nakano; T Mori
Induction of unresponsiveness in rats after either intraportal injection of donor antigen or intravenous injection combined with splenectomy.
Transplantation 1993;56(6):1468-72.
1993: Hiroaki Nagano; Morito Monden; M Gotoh; T Tanigawa; Y Nakano; T Tono; T Mori
Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
Transplantation proceedings 1993;25(1 Pt 1):352-3.
1992: Hiroaki Nagano; Morito Monden; M Gotoh; Y Nakano; T Tono; T Fukuzaki; T Tanigawa; T Mori
Mechanisms involved in immunosuppression induced by intraportal injection of donor spleen cells in rats.
Transplantation proceedings 1992;24(6):2900-1.
1991: T Fukuzaki; M Gotoh; Morito Monden; Keizo Dono; H Wada; T Tono; Hiroaki Nagano; T Kanai; T Mori
Induction of tolerance to islet allografts with preoperative donor spleen cell injection and a short course of FK 506 treatment.
Transplantation proceedings 1991;23(6):3221-2.